Browsing byAuthorAmmar, Usama M.
Showing results 1 to 16 of 16
| Issue Date | Title | Author(s) |
|---|---|---|
| 2022-06 | 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation | Elsherbeny, Mohamed H.; Ammar, Usama M.; Abdellattif, Magda H.; Abourehab, Mohammed A. S.; Abdeen, Ahmed; Ibrahim, Samah F.; Abdelrahaman, Doaa; Mady, Wessam; Roh, Eun Joo; Elkamhawy, Ahmed |
| 2024-04 | 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation (vol 12, 8Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life 2022, 12, 87676, 2022) | Elsherbeny, Mohamed H.; Ammar, Usama M.; Abdellattif, Magda H.; Abourehab, Mohammed A. S.; Abdeen, Ahmed; Ibrahim, Samah F.; Abdelrahaman, Doaa; Mady, Wessam; Roh, Eun Joo; Elkamhawy, Ahmed |
| 2019-05-15 | Anticancer profile of newly synthesized BRAF inhibitors possess 5-(pyrimidin-4-yl)imidazo[2,1-b]thiazole scaffold | Abdel-Maksouda, Mohammed S.; Ammar, Usama M.; Oh, Chang-Hyun |
| 2020-06-01 | Design and synthesis of novel pyrrolo[2,3-b]pyridine derivatives targeting (V600E)BRAF | Abdel-Maksoud, Mohammed S.; Ali, Eslam M. H.; Ammar, Usama M.; Mersal, Karim I.; Yoo, Kyung Ho; Oh, Chang-Hyun |
| 2021-02-01 | Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38 alpha/MAPK14 inhibitor | Ali, Eslam M. H.; Abdel-Maksoud, Mohammed S.; Hassan, Rasha Mohamed; Mersal, Karim I.; Ammar, Usama M.; Se-In, Choi; He-Soo, Han; Kim, Hee-Kwon; Lee, Anna; Lee, Kyung-Tae; Oh, Chang-Hyun |
| 2019-12 | Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors | Abdel-Maksoud, Mohammed S.; Ammar, Usama M.; El-Gamal, Mohammed I.; El-Din, Mahmoud M. Gamal; Mersal, Karim I.; Ali, Eslam M. H.; Yoo, Kyung Ho; Lee, Kyung-Tae; Oh, Chang-Hyun |
| 2021-01 | Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAF(V600E) inhibitors | Ali, Eslam M. H.; Abdel-Maksoud, Mohammed S.; Ammar, Usama M.; Mersal, Karim, I; Yoo, Kyung Ho; Jooryeong, Park; Oh, Chang-Hyun |
| 2021-04-05 | Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAF(V600E)/p38 alpha inhibitors | Ali, Eslam M. H.; El-Telbany, Rania Farag A.; Abdel-Maksoud, Mohammed S.; Ammar, Usama M.; Mersal, Karim, I; Zaraei, Seyed-Omar; El-Gamal, Mohammed, I; Choi, Se-In; Lee, Kyung-Tae; Kim, Hee-Kwon; Lee, Kwan Hyi; Oh, Chang-Hyun |
| 2021-10 | Design, synthesis, in vitro determination and molecular docking studies of 4-(1-(tert-butyl)-3-phenyl-1H-pyrazol-4-yl) pyridine derivatives with terminal sulfonamide derivatives in LPS-induced RAW264.7 macrophage cells | Mersal, Karim I.; Abdel-Maksoud, Mohammed S.; Ali, Eslam M. H.; Ammar, Usama M.; Zaraei, Seyed-Omar; Kim, Jae-Min; Kim, Su-Yeon; Lee, Kyung-Tae; Lee, Kwan Hyi; Kim, Si-Won; Park, Hyun-Mee; Ji, Mi-Jung; Oh, Chang-Hyun |
| 2021-05 | Discovery of New Imidazo[2,1-b]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma Activity | Abdel-Maksoud, Mohammed S.; El-Gamal, Mohammed, I; Lee, Bong S.; El-Din, Mahmoud M. Gamal; Jeon, Hong R.; Kwon, Dow; Ammar, Usama M.; Mersal, Karim, I; Ali, Eslam M. H.; Lee, Kyung-Tae; Yoo, Kyung Ho; Han, Dong Keun; Lee, Jae Kyun; Kim, Garam; Choi, Hong Seok; Kwon, Young Jik; Lee, Kwan Hyi; Oh, Chang Hyun |
| 2023-12 | Evaluation of novel pyrazol-4-yl pyridine derivatives possessing arylsulfonamide tethers as c-Jun N-terminal kinase (JNK) inhibitors in leukemia cells | Mersal, Karim I.; Abdel-Maksoud, Mohammed S.; Ali, Eslam M. H.; Ammar, Usama M.; Zaraei, Seyed-Omar; Haque, Md Mamunul; Das, Tanuza; Hassan, Noha F.; Kim, Eunice EunKyeong; Lee, Jun-Seok; Park, Hajeung; Lee, Kwan Hyi; El-Gamal, Mohammed I.; Kim, Hee-Kwon; Ibrahim, Tamer M.; Oh, Chang-Hyun |
| 2020-10-15 | Modification of imidazothiazole derivatives gives promising activity in B-Raf kinase enzyme inhibition; synthesis, in vitro studies and molecular docking | Ammar, Usama M.; Abdel-Maksoud, Mohammed S.; Mersal, Karim, I; Ali, Eslam M. H.; Yoo, Kyung Ho; Choi, Hong Seok; Lee, Jae Kyun; Cha, Sun Young; Oh, Chang-Hyun |
| 2018-10-05 | Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents | Ammar, Usama M.; Abdel-Maksoud, Mohammed S.; Oh, Chang-Hyun |
| 2021-09 | Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening | Elkamhawy, Ahmed; Ammar, Usama M.; Paik, Sora; Abdellattif, Magda H.; Elsherbeny, Mohamed H.; Lee, Kyeong; Roh, Eun Joo |
| 2022-04 | Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico study | Ibrahim Eslam Mohamed Hosny Ali; Karim Ibrahim Abdo Mersal; Ammar, Usama M.; Seyed Omar Zareei; Abdel-Maksoud, Mohammed S.; El-Gamal, Mohammed, I; Haque, Md Mamunul; Das, Tanuza; Kim, Eunice EunKyeong; Lee, Jun-Seok; LEE, KWAN HYI; Kim, Hee-Kwon; Oh, Chang Hyun |
| 2020-07 | Structural optimization of imidazothiazole derivatives affords a new promising series as B-Raf V600E inhibitors; synthesis, in vitro assay and in silico screening | Ammar, Usama M.; Abdel-Maksoud, Mohammed S.; Ali, Eslam M. H.; Mersal, Karim, I; Yoo, Kyung Ho; Oh, Chang-Hyun |
KIST 리포지터리는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.